According to a new report by Polaris Market Research, the global gynecology devices market was valued at USD 11.09 billion in 2024 and is projected to reach USD 25.81 billion by 2034, expanding at a CAGR of 8.8% over the forecast period. Growth is underpinned by rising population, improving healthcare access in emerging regions, and accelerating adoption of minimally invasive procedures across hospitals and ambulatory surgery centers.

What Is Driving Gynecology Devices Market Growth?

Demand is climbing as growing policy and social emphasis on women's health converges with rapid technological advancement in imaging, robotics, and diagnostics. Governments, NGOs, and healthcare institutions are prioritizing reproductive health screening and early cancer detection, pushing gynecology device adoption across hospitals and clinics. Polaris analysts note that the aging female population positions the surgical devices segment for sustained growth through 2034, with hospitals and clinics emerging as the largest revenue contributor and diagnostic imaging systems posting the fastest incremental gains.

Key Trends Shaping the Gynecology Devices Industry

Minimally Invasive Surgery and Robotic-Assisted Systems

High-definition hysteroscopes and laparoscopes are improving visualization during surgeries, while robotic-assisted systems enable surgeons to perform complex operations with greater control, reducing complications and procedural time across hospitals and ambulatory surgical settings.

Advances in Diagnostic Imaging Technology

Imaging equipment such as ultrasound devices, MRI, and hysterosalpingography are increasingly used to diagnose infertility, pelvic pain, and abnormal bleeding, with improved resolution and accuracy enabling earlier, more accurate treatment planning.

Shift Toward Outpatient and Ambulatory Care

Advancements in surgical equipment and anesthesia techniques are enabling quicker recovery and same-day discharge, driving a growing share of gynecological procedures into ambulatory surgery centers that offer shorter wait times and lower overhead costs.

Read More @ https://www.polarismarketresearch.com/industry-analysis/gynecology-devices-market

Market Segmentation: Breaking Down the Gynecology Devices Market

Polaris segments the gynecology devices market by product and end user, giving each buyer persona a citable, standalone data point for market forecast analysis.

By Product

The surgical devices segment dominated with the largest share in 2024, driven by the rising prevalence of uterine fibroids, endometriosis, and ovarian cysts requiring surgical intervention. The diagnostic imaging systems segment is expected to experience significant growth as early detection and accurate diagnosis gain emphasis.

By End User

Hospitals and clinics dominated with the largest share in 2024, offering comprehensive care and advanced diagnostic and surgical infrastructure for both routine and complex cases. Ambulatory surgery centers are expected to experience significant growth as outpatient care becomes more prevalent for minor and minimally invasive procedures.

Regional Outlook: Where Is Gynecology Devices Growing Fastest?

North America dominated the gynecology devices market with the largest revenue share in 2024, driven by advanced healthcare infrastructure and high healthcare spending, while Asia Pacific is projected to witness substantial growth through 2034, supported by a rising population and improving healthcare infrastructure. Within North America, the U.S. remains the largest single market, supported by strong R&D investment and FDA-backed regulatory clarity; within Asia Pacific, China is a primary growth engine, aided by healthcare reforms and rising insurance coverage. Europe rounds out the top three, supported by universal healthcare access and a strong medical device manufacturing base, led by Germany.

Competitive Landscape: Leading Gynecology Devices Companies

Key players profiled in the report include Medtronic plc, Boston Scientific Corp., Stryker Corp., Ethicon, Inc. (Johnson & Johnson MedTech), and Hologic, Inc., who are focusing on product innovation and geographic expansion to strengthen market position across the surgical devices and hospitals and clinics segments outlined above. Recent moves include Minerva Surgical's May 2025 launch of the HERizon Hysto-Kit for streamlined office-based hysteroscopy and Aspivix's February 2025 launch of Carevix, a gentler cervical device now available across the U.S., EU, UK, and Brazil.

Why It Matters for Buyers Evaluating Women's Health Device Suppliers

For stakeholders researching women's health procurement and investment, this report benchmarks gynecology devices market share, segment-level pricing, and forecast data — by product, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking diagnostic imaging systems as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

Vertical Software Market

Calcium Carbonate Market

IT Services Market

Neuroprosthetics Market

Laparoscopic Retrieval Bag Market

Cancer Pain Management Market

Cancer Biomarkers Market

Paraffin Wax Market

Membranes Market